Crossfire Oncology
Manufacturing · Netherlands · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Kloosterstraat 9, Oss, North Brabant, 53...Website
www.crossfire-oncology.comRevenue
<$5 MillionIndustry
About Crossfire Oncology
Is Crossfire Oncology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Crossfire Oncology recently announced quarterly report
Check out if Crossfire Oncology is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Crossfire Oncology launches new products
Funding: Get notified immidiatlly once Crossfire Oncology has new funding data
Click to see if Crossfire Oncology had a recent Job posting/layoffs
Check if Crossfire Oncology has recently received funding, and reach out quickly before it becomes old news!
Crossfire Oncology, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Crossfire Oncology
Recommended Actions
Find VP level buyers at Crossfire Oncology
Find 2 more new buyers
Company Profile Activity
Activity Insights
Crossfire Oncology is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Crossfire Oncology is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Crossfire Oncology.
Crossfire Oncology Tech Stack
A closer look at the technologies used by Crossfire Oncology
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Crossfire Oncology
At Crossfire Oncology the company approach kinases from three different angles: inhibitors, degraders, and degrader antibody conjugates. This tailored approach allows the company to design kinase targeting drugs that aim to maximize the therapeutic benefit for cancer patients.... Read More